Your Health, We Care
Ritlecitinib is a kinase inhibitor indicated for the treatment of severe alopecia areata in adults and adolescents12 years and older.
Limitations of Use: Not recommended for use in combination with other JAK inhibitors, biologic immunomodulators, cyclosporine or other potent immunosuppressants.
from FDA，2023.06
When should Ritlecitinib NOT be used?Before starting treatment with Ritlecitinib···【more】
Release date：2026-05-18Recommended：75
Mechanism of Action and Use of RitlecitinibRitlecitinib is a hard capsule contai···【more】
Release date：2026-05-18Recommended：72
Uses of RitlecitinibThe core active ingredient of Ritlecitinib is ritlecitinib. ···【more】
Release date：2026-05-14Recommended：80
Suitable for treating severe alopecia areata in adults and adolescents aged 12 a···【more】
Release date：2026-01-06Recommended：46
Telegram name: Vira
Name: LUCIUS
No.:0085253923643
